Complete results anticipated to be shared in early 2024CAMBRIDGE, Mass.--(BUSINESS WIRE)--#Lungcancer--RS Oncology, a clinical stage biotechnology company developing innovative therapies to eradicate mesothelioma and other diseases, today announced the completion of the Phase 1 dose escalation portion of the MITOPE...
Related Keywords
Cambridge , Cambridgeshire , United Kingdom , Massachusetts , United States , Jarrett Duncan , George Naumov , , United Kingdom Based ,
comparemela.com © 2020. All Rights Reserved.